ULIP for NRIs — Why the Indian Tax-Free Story and the US Tax Story Are Completely Different

If you're a US-resident NRI who's been pitched a ULIP as "tax-free under Section 10(10D)," there's a critical gap in that pitch you need to know about before buying — or if you already own one.

The Pitch You've Likely Heard

ULIPs are commonly sold with a specific pitch: market-linked returns, life insurance cover, and tax-free maturity proceeds under Section 10(10D) of India's Income Tax Act. This is accurate under Indian law, for Indian tax residents. For a US-resident NRI, this pitch is missing a critical, expensive piece of the picture.

Why the US Sees It Completely Differently

US tax law has its own specific test — under Internal Revenue Code Section 7702, known as the Cash Value Accumulation Test — to determine whether a product genuinely qualifies as life insurance for US tax purposes. Most Indian ULIPs fail this test, because their investment component is proportionally too large relative to the actual death benefit provided. When a policy fails this test, the IRS "looks through" the insurance wrapper entirely and taxes the underlying investment portion as a Passive Foreign Investment Company (PFIC) — the same harsh classification that applies to Indian mutual funds, covered in detail in our separate PFIC article.

What This Actually Means in Practice

• India's Section 10(10D) exemption does nothing on the US side — it's an Indian tax provision with no bearing on US tax obligations
• Default PFIC tax treatment applies — gains and surrender proceeds get taxed at the top US ordinary rate, with an interest charge for the deferral period, rather than the "tax-free" outcome the Indian marketing implies
• Form 8621 filing is required annually — for each ULIP held, adding real, recurring compliance cost and complexity
• A separate 1% excise tax may apply under a different US tax provision (Section 4371) on ULIP premiums paid while you're a US tax resident — a distinct cost layer on top of the PFIC treatment itself
• In some complex cases, a ULIP might even be classified as a foreign trust, triggering Form 3520 — a filing that carries a notably severe penalty structure for non-disclosure

Why This Catches So Many NRIs Off Guard

A ULIP doesn't look like the kinds of assets NRIs are typically warned to report on their US taxes — it's presented and understood in India as an insurance product, not an investment fund. This framing gap is precisely why many US-resident NRIs holding ULIPs are, without realizing it, out of compliance on US reporting requirements they didn't know applied to what they believed was simply a life insurance policy.

If You're a US-Resident NRI Considering a ULIP

Given this, a fresh ULIP purchase is very likely not the right vehicle if you're a US tax resident — the combination of PFIC tax treatment, Form 8621 compliance costs, and the excise tax layer typically makes a combination of pure term insurance (for protection) plus separate investing (through vehicles that don't trigger PFIC treatment) a cleaner approach for most US-resident NRIs, worth discussing specifically with a cross-border tax professional before purchasing.

If You're a US-Resident NRI Who Already Owns One

The Bottom Line

This is one of the most consequential, least understood gaps in NRI financial planning for the US specifically — a product genuinely tax-advantaged under Indian law can be genuinely tax-disadvantaged under US law, with real compliance costs on top. If you're a US person and own or are considering a ULIP, this deserves a direct, specific conversation with a cross-border tax professional — not an assumption based on how it was marketed in India.